Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Commentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma.

Hasserjian RP, Ott G, Elenitoba-Johnson KS, Balague-Ponz O, de Jong D, de Leval L.

J Hematop. 2009 Jul;2(2):89-95. doi: 10.1007/s12308-009-0039-7. Epub 2009 Jun 27.

2.

Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.

Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH.

Am J Surg Pathol. 2013 Mar;37(3):323-32. doi: 10.1097/PAS.0b013e31826cebad.

PMID:
23348205
3.

Non-Hodgkin's lymphoma: the old and the new.

Cabanillas F.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S87-90. doi: 10.1016/j.clml.2011.03.029. Epub 2011 Apr 28. Review.

PMID:
22035756
4.

Clinicopathological Analysis of B Cell Lymphomas, Unclassifiable; with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma in a Tertiary Care Hospital in Southern India.

Selvi SK, Kar R, Basu D, Jacob SE, Dubashi B.

Indian J Hematol Blood Transfus. 2016 Jun;32(2):168-75. doi: 10.1007/s12288-015-0558-6. Epub 2015 May 30.

PMID:
27065578
5.

B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology.

Carbone A, Gloghini A, Aiello A, Testi A, Cabras A.

Hum Pathol. 2010 May;41(5):621-31. doi: 10.1016/j.humpath.2009.10.027. Review.

PMID:
20398809
6.

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.

Am J Surg Pathol. 2010 Mar;34(3):327-40. doi: 10.1097/PAS.0b013e3181cd3aeb.

7.

miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.

Zajdel M, Rymkiewicz G, Chechlinska M, Blachnio K, Pienkowska-Grela B, Grygalewicz B, Goryca K, Cieslikowska M, Bystydzienski Z, Swoboda P, Walewski J, Siwicki JK.

Tumour Biol. 2015 Jul;36(7):5377-88. doi: 10.1007/s13277-015-3203-y. Epub 2015 Feb 13.

PMID:
25677902
8.

Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.

Haralambieva E, Boerma EJ, van Imhoff GW, Rosati S, Schuuring E, Müller-Hermelink HK, Kluin PM, Ott G.

Am J Surg Pathol. 2005 Aug;29(8):1086-94.

PMID:
16006805
9.

Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients.

Lu B, Zhou C, Yang W, Huang H, Gao Z, He Y, Liu H, Zhou X, Gong L.

Leuk Lymphoma. 2011 Dec;52(12):2356-64. doi: 10.3109/10428194.2011.602772. Epub 2011 Aug 18.

PMID:
21740296
10.

Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis.

Choi SY, Kim SJ, Kim WS, Kim K, Ko YH.

Virchows Arch. 2011 Nov;459(5):495-502. doi: 10.1007/s00428-011-1153-3. Epub 2011 Oct 15.

PMID:
22002677
11.

Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.

Bürgesser MV, Gualco G, Diller A, Natkunam Y, Bacchi CE.

Ann Diagn Pathol. 2013 Jun;17(3):250-5. doi: 10.1016/j.anndiagpath.2012.11.001. Epub 2012 Dec 14.

PMID:
23246412
12.

Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.

Swerdlow SH.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):90-9. doi: 10.1182/asheducation-2014.1.90. Epub 2014 Nov 18. Review.

PMID:
25696840
13.

The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma.

Lin P, Medeiros LJ.

Curr Hematol Malig Rep. 2013 Sep;8(3):243-52. doi: 10.1007/s11899-013-0169-y. Review.

PMID:
23892979
14.

Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.

Bellan C, Stefano L, Giulia de F, Rogena EA, Lorenzo L.

Hematol Oncol. 2009 Dec;27(4):182-5. doi: 10.1002/hon.914. Review.

PMID:
19670467
15.

Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.

Boerma EG, Siebert R, Kluin PM, Baudis M.

Leukemia. 2009 Feb;23(2):225-34. doi: 10.1038/leu.2008.281. Epub 2008 Oct 16. Review.

PMID:
18923440
16.

Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.

Carey CD, Gusenleitner D, Chapuy B, Kovach AE, Kluk MJ, Sun HH, Crossland RE, Bacon CM, Rand V, Dal Cin P, Le LP, Neuberg D, Sohani AR, Shipp MA, Monti S, Rodig SJ.

J Mol Diagn. 2015 Jan;17(1):19-30. doi: 10.1016/j.jmoldx.2014.08.006. Epub 2014 Nov 7.

17.

Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.

Bellan C, Stefano L, Giulia de F, Rogena EA, Lorenzo L.

Hematol Oncol. 2010 Jun;28(2):53-6. doi: 10.1002/hon.916. Review.

PMID:
19844983
18.

Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?

Thomas DA, O'Brien S, Faderl S, Manning JT Jr, Romaguera J, Fayad L, Hagemeister F, Medeiros J, Cortes J, Kantarjian H.

Curr Hematol Malig Rep. 2011 Mar;6(1):58-66. doi: 10.1007/s11899-010-0076-4. Review.

19.

Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements.

Yoshida M, Ichikawa A, Miyoshi H, Kiyasu J, Kimura Y, Arakawa F, Niino D, Ohshima K.

Pathol Int. 2015 Oct;65(10):519-27. doi: 10.1111/pin.12335. Epub 2015 Jul 29.

PMID:
26224092
20.

Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement.

Pienkowska-Grela B, Rymkiewicz G, Grygalewicz B, Woroniecka R, Krawczyk P, Czyz-Domanska K, Walewski J.

Med Oncol. 2011 Dec;28(4):1589-95. doi: 10.1007/s12032-010-9614-0. Epub 2010 Jul 27.

PMID:
20661666
Items per page

Supplemental Content

Write to the Help Desk